Copper induces liver lipotoxicity disease by up-regulating Nrf2 expression via the activation of MTF-1 and inhibition of SP1/Fyn pathway

Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166752. doi: 10.1016/j.bbadis.2023.166752. Epub 2023 May 12.

Abstract

Excessive copper (Cu) intake leads to hepatic lipotoxicity disease, which has adverse effects on health, but the underlying mechanism is unclear. We found that Cu increased lipotoxicity by promoting Nrf2 recruitment to the ARE site in the promoters of five lipogenic genes (g6pd, 6pgd, me, icdh and pparγ). We also found that Cu affected the Nrf2 expression via different pathways: metal regulatory transcription factor 1 (MTF-1) mediated the Cu-induced Nrf2 transcriptional activation; Cu also enhanced the expression of Nrf2 by inhibiting the SP1 expression, which was achieved by inhibiting the negative regulator Fyn of Nrf2. These promoted the enrichment of Nrf2 in the nucleus and ultimately affected lipotoxicity. Thus, for the first time, we elucidated that Cu induced liver lipotoxicity disease by up-regulating Nrf2 expression via the MTF-1 activation and the inhibition of SP1/Fyn pathway. Our study elucidates the Cu-associated obesity and NAFLD for fish and possibly humans.

Keywords: Copper; Lipogenic metabolism; Lipotoxicity; Nrf2 signal; Oxidative stress; SP1-Fyn pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Copper* / toxicity
  • Humans
  • NF-E2-Related Factor 2 / genetics
  • NF-E2-Related Factor 2 / metabolism
  • Non-alcoholic Fatty Liver Disease* / genetics
  • Oxidative Stress
  • Sp1 Transcription Factor / genetics
  • Sp1 Transcription Factor / metabolism

Substances

  • Copper
  • NF-E2-Related Factor 2
  • SP1 protein, human
  • Sp1 Transcription Factor